Skip to main content
Log in

Toxicological studies with dithranol and its 10-acyl analogues

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The oral LD50 values of an antipsoriatic drug, dithranol, were 1542 mg/kg in NMRI mice and 3216 mg/ kg in Wistar rats. Three 10-acyl analogues of dithranol (10-acetyl, 10-propionyl and 10-butyryl dithranol or butantrone) were more toxic both in mice and rats. They were mutagenic only in TA1537 of the five Salmonella typhimurium strains tested. None of them were mutagenic in two Escherichia coli strains. Butantrone was least toxic to test bacteria and had the lowest mutagenic activity on TA1537. In metaphase analysis of in vitro treated human lymphocytes, dithranol, 10-acetyl dithranol and 10-propionyl dithranol produced significant increases in the number of chromosome and chromatid gaps but without a clear dose-response relationship, and without inducing significant breaks. Butantrone did not cause significant increases in gaps or breaks. In the mouse micronucleus test, dithranol and butantrone caused no increases in micronucleated polychromatic or normochromatic erythrocytes, indicating lack of clastogenic activity in vivo at maximum tolerated doses. Hence, dithranol and its 10-acyl analogues have a weak mutagenic activity in vitro. The mutagenic activity of butantrone is lower than that of the other analogues and dithranol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31: 347–364

    Google Scholar 

  • Bock FG, Burns R (1963) Tumor-promoting properties of anthralin (1,8,9-anthratriol). J Natl Cancer Inst 30: 393–397

    Google Scholar 

  • Brandt H, Mustakallio KK (1983) Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing. Acta Derm Venereol (Stockh) 63: 237–240

    Google Scholar 

  • Brown JP, Brown RJ (1976) Mutagenesis by 9,19-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res 40: 203–224

    Google Scholar 

  • Gaudin D, Cregg RS, Yielding KL (1972) Inhibition of DNA repair by cocarcinogens. Biochem Biophys Res Commun 72: 945–949

    Google Scholar 

  • Gillberg BO, Zetterberg G, Swanbeck G (1967) Petite mutants induced in yeasts by dithranol, an important therapeutic agent against psoriasis. Nature (London) 214: 415

    Google Scholar 

  • Gollapudi B, Kamra OP (1979) Application of a simple Giemsa-staining method in the micronucleus test. Mutat Res 64: 45–46

    Google Scholar 

  • Martinmaa J, Vanhala L, Mustakallio KK (1978) Free radical intermediates produced by autooxidation of 1,8-dihydroxy-9-anthrone (dithranol) in pyridine. Experientia 34: 872

    Google Scholar 

  • Männistö PT, Havas A, Haasio K, Hanhijärvi H, Mustakallio KK (1984a) Skin irritation by dithranol (anthralin) and its 10-acyl analogues in three animal models Contact Dermatitis 10: 140–145

    Google Scholar 

  • Männistö PT, Vaissi L, Mustakallio KK, Viluksela M, Kosma VM, Collan Y (1984b) Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogues in the dorsal skin of female NMRI mice. J Pharmacol Exp Ther 229: 255–260

    Google Scholar 

  • McCann J, Choi E, Yamasaki E, Ames BN (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc Natl Acad Sci 72: 5135–5139

    Google Scholar 

  • Mustakallio KK (1979) Irritation and staining by dithranol (anthralin) and related compounds. I. Estimation with chamber testing and contact thermography. Acta Derm Venereol (Stockh) 59: 125–132

    Google Scholar 

  • Mustakallio KK (1980) Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues. Acta Derm Venereol (Stockh) 60: 169–172

    Google Scholar 

  • Mustakallio KK (1981) Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin. Br J Dermatol 105: 20–23

    Google Scholar 

  • Mustakallio KK, Brandt H (1984) Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone). Acta Derm Venereol (Stockh) 64: 63–66

    Google Scholar 

  • Mustakallio KK, Pippuri AK, Honkanen E (1981) Dihydroxy-acylanthrons having anti-psoriatic activity. U. S. Patent 4.299.846

  • Mustakallio KK, Brandt H, Halmekoski J, Vilvala R, Martinmaa J, Honkanen E, Pippuri A, Haarala J, Männistö P (1982) Structure-activity relationships among dithranol and its new derivatives. Poster in 16th Intern Congr Dermatol, Tokyo

  • National Board of Health (1961) Nordic Pharmacopoea, Finnish Edition, vol. IV, Helsinki, pp 31–35

  • Poirier MC, DeCicco BT, Liberman MW (1975) Nonspecific inhibition of DNA repair synthesis by tumor promoters in human diploid fibroblasts damaged with N-acetoxy-2-acetylaminofluorene. Cancer Res 35: 1392–1395

    Google Scholar 

  • Rogers S, Marks J, Shuster S, Vella Briffa D, Warin A, Greaves M (1979) Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet i: 455–458

    Google Scholar 

  • Scott D, Danford N, Dear B, Kirkland D, and Richardson C (1983) In vitro chromosome aberration assays. In: Dean BJ et al. (eds) UKEMS Sub-Committee on Guidelines for Mutagenicity Testing. Repert. Part I. Basic Test Battery. Published by United Kingdom Environmental Mutagen Society, Swansea

    Google Scholar 

  • Segal A, Katz C, VanDuuren BL (1971) Structure and tumor-promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds. J Med Chem 14: 1152–1154

    Google Scholar 

  • Siebert D, Zimmermann FK, Lemperle E (1970) Genetic effects of fungicides. Mutat Res 10: 533–543

    Google Scholar 

  • Swanbeck G, Hillström L (1971) Analysis of etiological factors of squamous cell skin cancers of different locations. Acta Derm Venereol 51: 151–156

    Google Scholar 

  • Tikkanen L, Matsushima T, Natori S (1983) Mutagenicity of anthraquinones in the Salmonella preincubation test. Mutat Res 116: 297–304

    Google Scholar 

  • Van Duuren BL, Segal A, Tseng S-S, Rusch GM, Loewengart G, Maté U, Roth D, Smith A, Melchionne S, Seidman I (1978) Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone). J Med Chem 21: 26–31

    Google Scholar 

  • Yasuhira K (1968) Skin papillomas production by anthralin painting after urethane initiation in mice. Gann 187–193

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Männistö, P.T., Kirkland, D., Viluksela, M. et al. Toxicological studies with dithranol and its 10-acyl analogues. Arch Toxicol 59, 180–185 (1986). https://doi.org/10.1007/BF00316330

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00316330

Key words

Navigation